These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15616234)

  • 1. Predictors of health care costs in adults with diabetes.
    Gilmer TP; O'Connor PJ; Rush WA; Crain AL; Whitebird RR; Hanson AM; Solberg LI
    Diabetes Care; 2005 Jan; 28(1):59-64. PubMed ID: 15616234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of office systems and improvement strategies on costs of care for adults with diabetes.
    Gilmer TP; O'Connor PJ; Rush WA; Crain AL; Whitebird RR; Hanson AM; Solberg LI
    Diabetes Care; 2006 Jun; 29(6):1242-8. PubMed ID: 16732003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of medical care for patients with diabetes, hypertension and both conditions: does alcohol use play a role?
    French MT; Mundt MP; Fleming M; Zavala SK
    J Intern Med; 2005 Jul; 258(1):45-54. PubMed ID: 15953132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost to health plans of poor glycemic control.
    Gilmer TP; O'Connor PJ; Manning WG; Rush WA
    Diabetes Care; 1997 Dec; 20(12):1847-53. PubMed ID: 9405905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes.
    Bansal M; Shah M; Reilly B; Willman S; Gill M; Kaufman FR
    Appl Health Econ Health Policy; 2018 Oct; 16(5):675-684. PubMed ID: 29936685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.
    O'Brien JA; Patrick AR; Caro J
    Clin Ther; 2003 Mar; 25(3):1017-38. PubMed ID: 12852716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of financial barriers on access to care, quality of care and vascular morbidity among patients with diabetes and coronary heart disease.
    Parikh PB; Yang J; Leigh S; Dorjee K; Parikh R; Sakellarios N; Meng H; Brown DL
    J Gen Intern Med; 2014 Jan; 29(1):76-81. PubMed ID: 24078406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and costs of hospital care for coronary heart disease related and not related to diabetes.
    Currie CJ; Morgan CL; Peters JR
    Heart; 1997 Dec; 78(6):544-9. PubMed ID: 9470868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada.
    Grima DT; Thompson MF; Sauriol L
    Pharmacoeconomics; 2007; 25(3):253-66. PubMed ID: 17335310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
    Khaw KT; Wareham N; Bingham S; Luben R; Welch A; Day N
    Ann Intern Med; 2004 Sep; 141(6):413-20. PubMed ID: 15381514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes.
    Wexler DJ; Grant RW; Meigs JB; Nathan DM; Cagliero E
    Diabetes Care; 2005 Mar; 28(3):514-20. PubMed ID: 15735180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.
    Schulze MB; Shai I; Manson JE; Li T; Rifai N; Jiang R; Hu FB
    Diabetologia; 2004 Dec; 47(12):2129-36. PubMed ID: 15662553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of an electronic medical record based clinical decision support system.
    Gilmer TP; O'Connor PJ; Sperl-Hillen JM; Rush WA; Johnson PE; Amundson GH; Asche SE; Ekstrom HL
    Health Serv Res; 2012 Dec; 47(6):2137-58. PubMed ID: 22578085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study.
    Forrest KY; Becker DJ; Kuller LH; Wolfson SK; Orchard TJ
    Atherosclerosis; 2000 Jan; 148(1):159-69. PubMed ID: 10580182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with higher hemoglobin A1c and type 2 diabetes-related costs: Secondary data analysis of adults 18 to 64 in Texas with commercial insurance.
    Ory MG; Han G; Jani SN; Zhong L; Andreyeva E; Carpenter K; Towne SD; Preston VA; Smith ML
    PLoS One; 2023; 18(9):e0289491. PubMed ID: 37682942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).
    Barnett AH; Millar HL; Loze JY; L'Italien GJ; van Baardewijk M; Knapp M
    Eur Arch Psychiatry Clin Neurosci; 2009 Jun; 259(4):239-47. PubMed ID: 19267255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of lower-extremity ulcers among patients with diabetes.
    Stockl K; Vanderplas A; Tafesse E; Chang E
    Diabetes Care; 2004 Sep; 27(9):2129-34. PubMed ID: 15333473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical costs of managed care in patients with type 2 diabetes mellitus.
    Bhattacharyya SK; Else BA
    Clin Ther; 1999 Dec; 21(12):2131-42. PubMed ID: 10645758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime costs of complications resulting from type 2 diabetes in the U.S.
    Caro JJ; Ward AJ; O'Brien JA
    Diabetes Care; 2002 Mar; 25(3):476-81. PubMed ID: 11874933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions.
    Fu AZ; Qiu Y; Radican L; Wells BJ
    Diabetes Care; 2009 Dec; 32(12):2187-92. PubMed ID: 19729528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.